ArticleFrontiers in oncology2026

Identification of a novel ALK intergenic fusion in a resected high‑recurrence‑risk lung adenocarcinoma and adjuvant treatment with ensartinib: a case report.

Jing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.